603676 卫信康
2026/03 - 三个月2025/122024/122023/122022/12

盈利能力分析
净资产收益率 ROE (%)4.52516.27318.06216.71415.469
总资产报酬率 ROA (%)3.58012.51713.56112.43411.196
投入资产回报率 ROIC (%)4.38715.76417.48416.19215.144

边际利润分析
销售毛利率 (%)60.19161.45254.24450.81552.602
营业利润率 (%)25.00625.67921.60013.22811.627
息税前利润/营业总收入 (%)24.87924.86221.06115.99012.821
净利润/营业总收入 (%)21.21420.50218.93316.18112.653

收益指标分析
经营活动净收益/利润总额(%)96.21277.54083.62567.52391.578
价值变动净收益/利润总额(%)4.16012.3267.35211.3138.640
营业外收支净额/利润总额(%)-0.318-2.837-1.53818.93810.832

偿债能力分析
流动比率 (X)3.7403.7003.0793.0392.766
速动比率 (X)3.5813.5292.9812.9422.687
资产负债率 (%)20.82920.91725.26024.56826.710
带息债务/全部投入资本 (%)0.3750.4060.2150.3040.286
股东权益/带息债务 (%)25,894.47023,842.27945,013.63331,837.47233,929.867
股东权益/负债合计 (%)380.101378.081295.881307.033274.389
利息保障倍数 (X)-526.189-229.675-99.278-48.724-58.886

营运能力分析
应收账款周转天数 (天)39.40648.11348.57154.17552.967
存货周转天数 (天)41.35541.84224.29619.61314.994